The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2020

Filed:

Jun. 25, 2019
Applicants:

Clio, Inc., Akita, JP;

Gifu University, Gifu, JP;

Tohoku University, Miyagi, JP;

Inventors:

Masanori Yoshida, Akita, JP;

Shinya Minatoguchi, Gifu, JP;

Mari Dezawa, Miyagi, JP;

Assignees:

CLIO, INC., Akita, JP;

GIFU UNIVERSITY, Gifu, JP;

TOHOKU UNIVERSITY, Miyagi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 35/28 (2015.01); C12N 5/074 (2010.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); C12N 5/0607 (2013.01);
Abstract

An object of the present invention is to provide a novel medical application for use in regenerative medicine that uses pluripotent stem cells (Muse cells). The present invention provides a cell preparation for treating myocardial infarction, and particularly serious massive myocardial infarction and heart failure associated therewith, that contains pluripotent stem cells positive for SSEA-3 isolated from biological mesenchymal tissue or cultured mesenchymal cells. The cell preparation of the present invention is based on a cardiac tissue regeneration mechanism by which Muse cells are made to selectively accumulate in damaged myocardial tissue and differentiate into cardiac muscle in that tissue as a result of intravenous administration of Muse cells to a subject presenting with the aforementioned disorders.


Find Patent Forward Citations

Loading…